Recent Headlines
T-Cell Immunotherapy Market to be Worth USD 30 Billion by 2030, Predicts Roots Analysis
The “T-Cell Immunotherapy Market, 2015-2030” report provides an extensive study of the field of T-cell immunotherapy. With no marketed products, this emerging field is still in its infancy; the report provides a comprehensive view of the market segmented into the following three sub-groups: CAR-T therapies, TCR therapies and TIL therapies. - October 13, 2015 - Roots Analysis
CHI to Host Roundtable Discussions at Optimizing Bioassays for Biologics Conference
Moderated by Drs. Han Li, Bristol-Myers Squibb; Maura C. Kibbey, United States Pharmacopeia (USP); and Max L. Tejada, Gilead Sciences - October 10, 2015 - Cambridge Healthtech Institute
Bioo Scientific Showcases Solutions Designed to Improve Exome Capture at ASHG 2015
At ASHG 2015, Bioo Scientific is launching a number of new kits for the improvement of in-solution exome and custom target capture. These kits offer optimized library prep, blocking and barcoding, interfacing with Agilent SureSelect XT and XT2 systems and Roche’s Nimblegen SeqCap systems. ASHG is the largest human genetics meeting and expo worldwide, providing a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. - October 09, 2015 - Bioo Scientific
Public Health of Castilla La Mancha Opts for the Legipid Rapid Test for Detecting Legionella in Water
The Public Health Laboratories of Castilla La Mancha (Spain) have introduced the Legipid® Legionella Fast Detection kit to determine Legionella in water. This kit was developed by the company Biotica Bioquimica Analitica (www.biotica.es), which belongs to the Science, Technology and Business Park of the Universitat Jaume I (Espaitec). - October 08, 2015 - Biotica Bioquimica Analitica
New Research Identifies Leading Clinical CROs Best Positioned for Future Success
New Research Identifies Future Leadership and Benchmarks CRO Operational Performance with over 160 Clinical Outsourcing Decision Makers - October 07, 2015 - Life Science Strategy Group, LLC
Recursion Pharma Receives Orphan Drug Designation for Hereditary Stroke Disorder
Recursion Pharmaceuticals, a drug discovery start-up company, announced receipt of an Orphan Drug Designation from the FDA for the use of Tempol for the treatment of Cerebral Cavernous Malformation, a hereditary stroke disease. Recursion expects this will be the first of many potential treatments identified using their proprietary drug discovery platform. - October 05, 2015 - Recursion Pharmaceuticals
ELISA Biology Contract Research Services Provided by Altogen Labs
Enzyme Linked Immunosorbent Assay (ELISA) is a widely used laboratory research assay designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones. ELISA is a very accurate, highly sensitive and specific immunoassay in comparison to other types of common... - October 03, 2015 - Altogen Labs
Regulate Gene Expression with Altogen Labs RNAi Technology
Ribonucleic Acid or RNA is a molecule critical to biology because it is behind the coding, regulation and expression of genes. With the RNA Interference or RNAi technology service offered by Altogen Labs it is possible to effectively regulate gene expression. Moreover, Altogen Labs has developed... - October 03, 2015 - Altogen Labs
Altogen Biosystems Releases Competitive In Vivo Polymer Kit
Altogen Biosystems has exclusively developed a highly effective In Vivo Polymer Transfection Kit that is capable of delivering siRNA, mRNA, small proteins, and DNA into various rodent tissues for pre-clinical and laboratory research. The efficacy of the Altogen Biosystems new in vivo transfection... - October 02, 2015 - Altogen Biosystems
New Generation of Tissue-Targeted Nanoparticle Based In Vivo Transfection Kit for Animal Research Developed by Altogen Biosystems
Researchers can now effectively deliver molecular targeted medicines into a myriad of tissues using nanotechnology. Altogen Biosystems has developed a new generation of highly efficient Nanoparticle-based In Vivo Transfection Kit that it exclusively manufactures. Nanoparticle technology can be... - October 02, 2015 - Altogen Biosystems
Altogen Biosystems Offers PEG-Liposome In Vivo Transfection Kit
Altogen Biosystems has developed a highly efficient in vivo transfection reagent capable of delivery cargo molecules (siRNA, miRNA, pDNA, and small proteins) into multiple tissues including spleen, kidney, pancreas, liver, and tumors. In vivo transfection is a laboratory research method utilized by... - October 02, 2015 - Altogen Biosystems
Ixogel® is Granted QIDP Status by the US Food and Drug Administration
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the U.S. Food and Drug Administration (FDA) has designated the company's lead product candidate, Ixogel®, as a Qualified Infectious Disease Product (QIDP) for the prevention of Lyme Disease after a tick bite and is working with the company on the phase III protocol. Special Protocol Assessment (SPA) confirmation expected soon. - September 29, 2015 - Ixodes AG
Bioo Scientific Releases Automated Small RNA Library Prep Protocol for the Sciclone NGS Workstation
Bioo Scientific has automated bias-reducing small RNA library prep on the Sciclone® NGS and NGSx Workstations, automating the NEXTflex™ Small RNA-Seq Library Prep Kit v2 and increasing productivity by reducing the time and labor costs associated with small RNA library prep. - September 26, 2015 - Bioo Scientific
MoBiTec GmbH to Attend BIOTECHNICA 2015, Germany - See ZDGSY's Inimitable GS-Key, an Amazingly Small and Fast DNA Extraction Device
BIOTECHNICA - Europe's No.1 Event for Biotechnology, Life Sciences, and Lab Technology! At MoBiTec's booth, cutting-edge technologies will be presented. Highlight: An incredibly small and fast handheld device for DNA extraction! - September 25, 2015 - MoBiTec GmbH
Bioo Scientific Showcases Innovative Solutions for Rapid Food Safety Testing at AOAC 2015
Bioo Scientific will exhibit its latest advances in food and feed safety and quality testing, at booth #502 of the 129th AOAC Annual Meeting, September 27-30 in Los Angeles, CA. New technologies include the most sensitive test available for histamine screening, a sulfite detection method which overcomes issues with problematic “high-creep” samples, optimized immunoaffinity columns for mycotoxin analysis, and a solution for high-throughput detection of amantadine residues in poultry. - September 25, 2015 - Bioo Scientific
Bioo Scientific Launches Enzymatic Assay for Accurate Homocysteine Analysis in Model Organisms
Bioo Scientific has released the MaxDiscovery™ Homocysteine Enzymatic Assay Kit. This kit uses a new enzymatic technology for spectrophotometric detection of total homocysteine levels in serum from rodents and other mammals. This kit enables the determination of hyperhomocysteinemia, or elevated levels of total homocysteine (tHcy) in the blood, which is an independent risk factor for neural tube defects, vascular diseases and Alzheimer’s disease, and other diseases. - September 23, 2015 - Bioo Scientific
MoBiTec to Offer ProteoGREEN™-gGlu, a Fluorogenic Probe for Specific Detection of Cancer Cells
ProteoGREEN™-gGlu is a cancer-selective fluorogenic imaging probe that is rapidly activated to a highly fluorescent compound. The membrane-permeable dye is suitable for live cells or in vivo imaging of cancer cells. - September 18, 2015 - MoBiTec GmbH
MD Anderson, Cayman Chemical, and Fannin Innovation Studio Form Therapeutics Company
The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of... - September 17, 2015 - Cayman Chemical Company
Cayman Chemical and the University of Michigan Issued US Patent for SAM-Screener™ Epigenetic Methylation Test
The United States Patent and Trademark Office has issued a patent to Cayman Chemical and the University of Michigan claiming detection analyte probes based on a natural product mimic of the methyltransferase cofactor S-adenosylmethionine (SAM). Aptly named SAM-Screener™, these probes are the foundation of Cayman’s high-throughput, one-step florescent binding assays for identification of SAM-competitive methyltransferase inhibitors from small-molecule chemical libraries. - September 10, 2015 - Cayman Chemical Company
Bioo Scientific Receives USDA Approval for Using Its ELISA to Screen Meat for Ractopamine Residues
Bioo Scientific’s MaxSignal® Ractopamine ELISA Test Kit has been approved by the USDA for the verification testing requirements for screening of meat in the Quality System Verification Program (QSVP), Never Fed Beta-Agonists Marketing Program. The kit enables the detection of as little as 0.1 ppb of ractopamine in pork and other meat samples, well below the 1 ppb minimal required performance limit used by many countries. - September 04, 2015 - Bioo Scientific
NASH Drugs Market, 2015-2025
The "NASH Drugs Market, 2015-2025" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of molecules in this area. With an expanding NAFLD and NASH population worldwide, there is a growing need for development of therapeutics in this disease area. - September 03, 2015 - Roots Analysis
Protein Expression Systems Market: Current Landscape and Future Opportunities
Advances in genetic engineering and cloning techniques have allowed isolation and expression of heterologous and recombinant proteins for research, therapeutic and industrial uses. Large scale applications such as enzyme, antibody or vaccine production require high amounts of protein. This demands that the system producing protein must be easy to culture, allow rapid cell growth and provide good yield. - September 02, 2015 - Roots Analysis
VIRUN® NutraBIOsciences™ Relocates R&D to Pomona, Presenting at Upcoming Cognitive Health Online Summit, Exhibiting at SupplySideWest & Announces VIRUN T-Shirt Trend
The Cognitive Health Online Summit will occur on September 2, 2015, and will feature Philip Bromley discussing Smart Delivery Technologies. VIRUN signs a lease for a new R&D facility in Pomona, California. SupplySide West Expo 2015 is right around the corner, and VIRUN is sure to be a crowd pleaser as it goes back in time to deliver the future of functional beverages. VIRUN has added a “Shop VIRUN” page to proliferate the VIRUN phenomenon. - September 01, 2015 - VIRUN
KinderPharm LLC Acquires Clinical Pharmacology and Pharmacometric Research and Development Company
KinderPharm LLC., announced that it has acquired PKPD Bioscience, Inc., a clinical pharmacology and pharmacometric research and development company. The purchase will strengthen the capabilities of KinderPharm LLC to provide pediatric PK/PD modeling and simulation as well as Pop PK and sparse sampling. - September 01, 2015 - KinderPharm LLC
Keynote Line-Up and Seven FDA Speakers Confirmed for Immunogenicity and Bioassay Summit 2015, Organized by Cambridge Healthtech Institute
Seventh annual event to focus on technologies and strategies for safe and efficacious products in the clinic. - August 31, 2015 - Cambridge Healthtech Institute
Bioo Scientific Honored for Increasing Austin’s Ability to Compete in the Global Marketplace
Bioo Scientific, an Austin-based biotech company which manufactures food and feed safety test kits and products supporting life science research, received the British Airways International Trade, Investment & Expansion Award, which recognizes investments by international companies in Austin that create jobs locally, as well as Austin-based companies who have a global impact through products and services provided worldwide. - August 30, 2015 - Bioo Scientific
Bioo Scientific Enables the Sensitive Detection of a Broad Range of Beta-Lactam Antibiotics in Food
Bioo Scientific’s MaxSignal® Beta-Lactam ELISA Test Kit has been validated for the screening of a wide range of beta-lactam antibiotics in a number of food matrices, with detection limits as low as 0.8 ppb. - August 27, 2015 - Bioo Scientific
Eurogentec (EGT), Belgium, Appoints MoBiTec GmbH as Distributor for Germany
Eurogentec (EGT) is a leading provider of innovative products and services to the life science, diagnostic, and pharmaceutical community. MoBiTec is selling the products of AnaSpec, which now is part of EGT, for more than 10 years already. The agreement allows MoBiTec to also offer EGT's state-of-the-art qPCR kits, oligonucleotides, and further products related to genomics to its customers. - August 14, 2015 - MoBiTec GmbH
KinderPharm Raises $1 Million to Further Advance Pediatric Drug Development
KinderPharm, a full-service contract research organization (CRO) dedicated exclusively to pediatric drug development, has raised $1 million from a Series A comprised of individuals, companies and angel investors. The $1 million investment will be used to further advance the clinical development of new medicines for children. - August 13, 2015 - KinderPharm LLC
ADC Contract Manufacturing Market: Opportunities Ahead
Antibody Drug Conjugates (ADCs) are a new class of therapeutic drugs consisting of a cytotoxic drug linked to a monoclonal antibody. These novel conjugates are believed to be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. - August 10, 2015 - Roots Analysis
The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor
AmnioChor is a biotech startup engaged in perinatal stem cell technologies, founded with a long term vision and operating on a near term mandate. The vision is the ability to satisfy the therapeutic needs of Mesenchymal and Epithelial stem cells as the critical high volume foundation of new cures. The immediate mandate is to create the bank to serve that need through the cryopreservation of the living amniotic membrane of the placental sac. - August 06, 2015 - AmnioChor
Bioo Scientific Increases Multiplexing Capabilities for Illumina Sequencing with >2000 Single-Index Barcodes
Bioo Scientific has released NEXTflex-HT™ Barcodes, single-index barcodes for Illumina sequencing, significantly increasing throughput capacity for next generation sequencing. The NEXTflex-HT Barcodes permit dual error correction to preventing ambiguity in sample differentiation due to PCR errors or sequencing instrument miscalling. Each pair of consecutive barcodes is fully color balanced and suitable for low level multiplexing. - July 24, 2015 - Bioo Scientific
MiTeGen Announces Mutual Distribution Agreements with Rigaku Reagents
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed mutual distribution agreements with Rigaku Reagents. - July 23, 2015 - MiTeGen, LLC
Global Biosimilars Market, 2015-2025
Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously, manufacturers are on the lookout for novel strategies that will help them attain maximum returns on investment. - July 22, 2015 - Roots Analysis
Drip & Prep – RNA Isolation Has Never Been so Easy; FortiusBio LLC do Cell Lysis Cards to the Utmost
MoBiTec GmbH's new partner FortiusBio LLC is a US startup biotech firm that does only one thing good: to soak filter paper with proprietary lysis solutions and make cards which lyse cells and preserve nucleic acid (even RNA) integrity at room temperature. - July 22, 2015 - MoBiTec GmbH
Non-Tyrosine Kinase Inhibitors Market to Witness 9% Annualized Growth, Predicts Roots Analysis
Roots Analysis has announced the addition of “Non-Tyrosine Kinase Inhibitors in Oncology, 2015-2025” report to their offering. The report provides a comprehensive analysis of the current market landscape and the future outlook of kinase inhibitors not specifically targeting tyrosine... - July 16, 2015 - Roots Analysis
A Fully Functional Diagnostic Laboratory in a Box - MoBiTec GmbH, Germany, Offers Coyote Bioscience's MD-Box-Lab
Whether a veterinarian in the field or a tropical disease specialist in the savanna - one of the things they certainly do miss most is a fully operational laboratory for reliable molecular biologically supported diagnostics. - July 15, 2015 - MoBiTec GmbH
Bioo Scientific Releases Enzyme Assay for Sulfite Detection in Food and Beverage Samples
Bioo Scientific’s MaxSignal® Sulfite Assay Kit, is a convenient and robust system optimized for the screening of the preservative sulfite that is highly prevalent in food and beverage samples. This enzyme assay uses a rapid aqueous extraction, and an enzymatic reaction that requires only 20 minutes. The kit can detect as little as 0.5 ppm of sulfite in aqueous extractions, and incorporates an innovative new format which offers more accurate results when testing “high-creep" samples. - July 10, 2015 - Bioo Scientific
Companion Diagnostics Market to Grow at 22.9% Over the Next Decade, Predicts Roots Analysis
Roots Analysis has announced the addition of “Companion Diagnostics Market, 2014 - 2024 (2nd edition)” report to their offering. The study offers an extensive analysis of this growing market, including market forecasts for the period 2014-2024. Shefali Asija, the principal analyst... - July 09, 2015 - Roots Analysis
Pharmaceutical Anti-Counterfeiting Technologies Market
The problem of counterfeit products has been a common challenge to all the industries across the globe. Counterfeit drugs create substantial public health hazards and cause crucial safety concerns. This field has attracted several companies which have developed many technologies with an aim to prevent counterfeiting in the pharma industry. - July 06, 2015 - Roots Analysis
Immune Checkpoint Inhibitors Market to Witness 24.1% Annualised Growth, Predicts Roots Analysis
Roots Analysis has announced the addition of "Immune Checkpoint Inhibitors Market - 2014 - 2024" report to their offering. The study offers a comprehensive view of the emerging market of CTLA-4, PD-1, PD-L1 and several novel immune checkpoint inhibitors (IDO-1, IDO-2, KIR, OX40, CD70,... - July 05, 2015 - Roots Analysis
Spaulding Clinical Research, LLC Expands Clinical Pharmacology Capabilities
CRO Completes 65-Bed Expansion to Increase Capacity to 200-Beds - July 05, 2015 - Spaulding Clinical Research, LLC
HPAPIs and Cytotoxic Drugs Manufacturing Market to Evolve Rapidly, Reports Roots Analysis
Roots Analysis has announced the addition of “HPAPIs and Cytotoxic Drugs Manufacturing Market” report to their portfolio. The report provides an extensive study of the contract manufacturing opportunity for this rapidly expanding market. It identifies various CMOs active in this space,... - July 04, 2015 - Roots Analysis
Rare Diseases: Market Opportunities Predicted by Roots Analysis
The report provides a comprehensive study of the pipeline drugs being developed for rare diseases by several top pharmaceutical firms. - July 03, 2015 - Roots Analysis
Prefilled Syringes Market, 2015-2025
Injectable drug delivery systems have traversed a long way from conventional syringes with vials to prefilled syringes, auto-injectors, pen injectors and needle free systems. These modern devices have become preferred devices for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week. - June 29, 2015 - Roots Analysis
Antibody Drug Conjugates: Contract Manufacturing Market to Evolve Rapidly, Predicts Roots Analysis
Roots Analysis has announced addition of the “Antibody Drug Conjugates: Contract Manufacturing Market 2014-2024” report to their offering. The report provides an extensive study of the contract manufacturing opportunity for this emerging class of therapeutics. It identifies various CMOs... - June 28, 2015 - Roots Analysis
Large Volume Wearable Injectors: from Conception to Reality
The focus of the latest edition is to provide a comprehensive analysis of the current state of the market, including detailed sales forecasts of these devices over the next ten years. - June 26, 2015 - Roots Analysis
AmoyDx, Supplier of MoBiTec, Germany, Introduces System for Extraction of Circulating DNA from NSCLC (Non-Small Cell Lung Cancer) Patients
Circulating cell-free DNA is an important emerging biomarker in cancer diagnostics as well as a non-invasive diagnostic solution for a wide range of clinical disorders. The AmoyDx kit is specially designed for effective isolation and purification of DNA from peripheral blood (serum or plasma) and pleural effusion. The purified DNA is suitable for downstream applications such as real-time quantitative PCR (qPCR). - June 26, 2015 - MoBiTec GmbH
Spaulding Clinical Research Adopts the Revolutionary ClinSpark™ eSource System
Spaulding Clinical Research, LLC, a full-service CRO headquartered in Southeastern Wisconsin announced today that they have completed the upgrade of their eSource platform and future capabilities to use Foundry Health, LLC’s ClinSpark™ system, the world’s only CDISC ODM certified... - June 19, 2015 - Spaulding Clinical Research, LLC
Bioo Scientific Launches One-component, Ready-to-Use TMB to Simplify ELISA Kits and Improve Their Stability
Bioo Scientific has released the new MaxSignal® TMB (3,3’,5,5’ – tetramethylbenzidine) Microwell Substrate Solution, a stable, one-component, ready-to-use TMB formulation which simplifies ELISAs, increasing accuracy by reducing potential errors. - June 17, 2015 - Bioo Scientific